Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Semmes

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Bone|September 17, 2019
Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent populationChenan Zhang, Helen M Hansen, Eleanor C Semmes, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
The Journal of Clinical Investigation|June 28, 2022
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infectionEleanor C Semmes, Itzayana G Miller, Courtney E Wimberly, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2012
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancerYunee Kim, Vladimir Ignatchenko, Cindy Q Yao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studiesJames F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
The Journal of Clinical Investigation|November 12, 2024
In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functionsEleanor C Semmes, Danielle R Nettere, Ashley N Nelson, et al.
Proteomics. Clinical Applications|June 19, 2013
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionJulius O Nyalwidhe, Lucy R Betesh, Thomas W Powers, et al.
Cancer|April 28, 2004
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinomaLajos Pusztai, Betsy W Gregory, Keith A Baggerly, et al.
Proteomics. Clinical Applications|July 3, 2020
Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype DeterminationJoseph J Otto, Vanessa L Correll, Hampus A Engstroem, et al.
Proteomics|July 30, 2005
Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkersAlex J Rai, Paul M Stemmer, Zhen Zhang, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Bone|September 17, 2019
Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent populationChenan Zhang, Helen M Hansen, Eleanor C Semmes, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
The Journal of Clinical Investigation|June 28, 2022
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infectionEleanor C Semmes, Itzayana G Miller, Courtney E Wimberly, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2012
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancerYunee Kim, Vladimir Ignatchenko, Cindy Q Yao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studiesJames F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
The Journal of Clinical Investigation|November 12, 2024
In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functionsEleanor C Semmes, Danielle R Nettere, Ashley N Nelson, et al.
Proteomics. Clinical Applications|June 19, 2013
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionJulius O Nyalwidhe, Lucy R Betesh, Thomas W Powers, et al.
Cancer|April 28, 2004
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinomaLajos Pusztai, Betsy W Gregory, Keith A Baggerly, et al.
Proteomics. Clinical Applications|July 3, 2020
Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype DeterminationJoseph J Otto, Vanessa L Correll, Hampus A Engstroem, et al.
Proteomics|July 30, 2005
Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkersAlex J Rai, Paul M Stemmer, Zhen Zhang, et al.
Pageof 23